The State of U.S. living kidney donors

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 10, 2010, Pages 1873-1880

  Davis, Connie L ^a   Cooper, Mathew ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; DATA BASE; DEATH; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE POLICY; HEALTH HAZARD; HEALTH INSURANCE; HEALTH STATUS; HISPANIC; HUMAN; HYPERTENSION; KIDNEY DONOR; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PROTEINURIA; RACE; REOPERATION;

ADOLESCENT; ADULT; ETHNIC GROUPS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; INSURANCE, HEALTH; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; NEPHRECTOMY; OBESITY; PROGNOSIS; PROTEINURIA; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; YOUNG ADULT;

EID: 77958592798     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01510210     Document Type: Article

References (61)

1. Ferris ME, Gipson DS, Kimmel PL, Eggers PW: Trends in treatment and outcomes of survival of adolescents initiating end-state renal disease care in the United States of America. Pediatr Nephrol 21: 1020-1026, 2006
2. Becker BN, Rush SH, Dykstra DM, Becker YT, Port FK: Preemptive transplantation for patients with diabetes-related kidney disease. Arch Intern Med 166: 44-48, 2006
3. Meier-Kriesche HU, Kaplan B: Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 74: 1377-1381, 2002
4. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT: Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 13: 1358-1364, 2002
5. United Network for Organ Sharing: Organ Procurement and Transplant Network data as of December 31, 2009. Available at www.unos.org.
6. Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD: Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 8: 2062-2070, 2008
7. Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, Gross CR, Matas AJ: Long-term consequences of kidney donation. N Engl J Med 360: 459-469, 2009
8. Garg AX, Prasad GV, Thiessen-Philbrook HR, Ping L, Melo M, Gibney EM, Knoll G, Karpinski M, Parikh CR, Gill J, Storsley L, Vlasschaert M, Mamdani M: Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada. Donor Nephrectomy Outcomes Research (DONOR) Network. Transplantation 86: 399-440, 2008
9. Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, Rosas-Arellano MP, Housawi A, Garg AX: Meta-analysis: risk for hypertension in living kidney donors. Donor Nephrectomy Outcomes Research (DONOR) Network. Ann Intern Med 145: 185-196, 2006
10. Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann: Pregnancy and birth after kidney donation: The Norwegian experience. Am J Transplant 9: 820-824, 2009
11. Ibrahim HN, Akkina SK, Leister E, Gillingham K, Cordner G, Guo H, Bailey R, Rogers T, Matas AJ: Pregnancy outcomes after kidney donation. Am J Transplant 9: 825-834, 2009
12. Mancilla E, Avila-Casado C, Uribe-Uribe N, Morales-Buenrostro LE, Rodríguez F, Vilatoba M, Gabilondo B, Aburto S, Rodriguez RM, Magana S, Magana F, Alberu J: Time-zero renal biopsy in living kidney transplantation: A valuable opportunity to correlate predonation clinical data with histological abnormalities. Transplantation 86: 1684-1688, 2008
13. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, Larson TS: Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 43: 112-119, 2004
14. Barri Y, Parker T III, Kaplan B, Glassock R: Primum non Nocere: Is chronic kidney disease staging appropriate in living kidney transplant donors? Am J Transplant 9: 657-660, 2009
15. Rook M, Bosma RJ, van Son WJ, Hofker HS, van der Heide JJ, ter Wee PM, Ploeg RJ, Navis GJ: Nephrectomy elicits impact of age and BMI on renal hemodynamics: Lower postdonation reserve capacity in older or overweight kidney donors. Am J Transplant 8: 2077-2085, 2008
16. Ramcharan T, Matas AJ: Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant 2: 959-964, 2002
17. Najarian JS, Chavers BM, McHugh LE, Matas AJ: 20 years or more of follow-up of living kidney donors. Lancet 340: 807-810, 1992
18. Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papaicik D, Rolin HA, Flechner S, Goormastic M, Novick AC: Renal outcome 25 years after donor nephrectomy. J Urol 166: 2043-2047, 2001
19. El-Agroudy AE, Sabry AA, Wafa EW, Neamatalla AH, Ismail AM, Mohsen T, Khalil AA, Shokeir AA, Ghoneim MA: Long-term follow-up of living kidney donors: A longitudinal study. BJU Int 100: 1351-1355, 2007
20. Sahay M, Narayen G, Anuradha: Risk of live kidney donation - Indian perspective. J Assoc Physicians India 55: 267-270, 2007
21. Gibney EM, King AL, Maluf DG, Garg AX, Parikh CR: Living kidney donors requiring transplantation: Focus on African Americans. Transplantation 84: 647-649, 2007
22. Ellison MD, McBride MM, Taranto SE, Delmonico FL, Kauffman HM: Living kidney donors in need of kidney transplants: A report from the Organ Procurement and Transplantation Network. Transplantation 74: 1349-1359, 2002
23. Fehrman-Ekholm I, Norden G, Lennerling A, Rizell M, Mjomstedt L, Olausson M: Incidence of end-stage renal disease among live kidney donors. Transplantation 82: 1646-1648, 2006 (Pubitemid 46035644)
24. Cherikh WS, Pan-Yen F, Taranto SE, Randall HB, Young CJ: Prior living kidney donors who were subsequently placed on the waiting list: An updated OPTN analysis. Am J Transplant 8: 335, 2008
25. McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V,Cushman M, Howard VJ, Howard G: Racial differences in the prevalence of chronic kidney disease among participants in the reasons for geographic and racial differences in stroke (REGARDS) cohort study. J Am Soc Nephrol 17: 1710-1715, 2006 (Pubitemid 43794674)
26. Hsu CY, Lin F, Vittinghoff E, Shlipak MG: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14: 2902-2907, 2003
27. Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, Brancati FL: Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol 13: 2363-2370, 2002
28. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Limmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184, 2008
29. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler J, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman DI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS: Family Investigation of Nephropathy and Diabetes Research Group. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192, 2008
30. Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, Divers J, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW: Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75: 736-745, 2009
31. Freedman BI, Kopp JB, Winkler CA, Nelson GW, Rao DC, Eckfeldt JH, Leppert MF, Hicks PJ, Divers J, Langefeld CD, Hunt SC: Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: The HyperGEN Study. Am J Nephrol 29: 626-632, 2009
32. Lamb EJ, Tomson CR, Roderick PJ: Clinical Sciences Reviews Committee of the Association for Clinical Biochemistry. Estimating kidney function in adults using formulae. Ann Clin Biochem 42: 321-345, 2005
33. Bia MJ, Ramos EL, Danovitch GM, Gaston RS, Harmon WE, Leichtman AB, Lundin PA, Neylan J, Kasiske BL: Evaluation of living renal donors: The current practice of U.S. transplant center. Transplantation 60: 322-327, 1995
34. Kasiske BL, Bia MJ: The evaluation and selection of living kidney donors. Am J Kidney Dis 26: 387-398, 1995
35. Mandelbrot DA, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Rodrigue JR: The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 7: 2333-2343, 2007
36. Iseki K, Ikemiya Y, Fukiyama K: Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 51: 850-854, 1997
37. Yamagata K, Iseki K, Nitta K, Imai H, Iino Y, Matsuo S, Makino H, Hishida A: Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol 12: 1-8, 2008
38. Iseki K, Ikemiya Y, Iseki C, Takishita S: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63: 1468-1474, 2003 (Pubitemid 36350012)
39. Lane C, Brown M, Dunsmuir W, Kelly J, Mangos G: Can spot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology? Nephrology 11: 245-249, 2006
40. Gai M, Motta D, Giunti S, Fop F, Masini S, Mezza E, Segoloni GP, Lanfranco G: Comparison between 24-h proteinuria, urinary protein/creatinine ratio and dipstick test in patients with nephropathy: Patterns of proteinuria in dipstick-negative patients. Scand J Clin Lab Invest 66: 299-307, 2006
41. Ogden CL, Carroll MD, McDowell MA, Flegal KM: Obesity among adults in the United States - No statistically significant change since 2003-2004. NCHS Data Brief 1: 1-8, 2007
42. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology 132: 2087-2102, 2007
43. Kokubo Y, Kamide K: High-normal blood pressure and the risk of cardiovascular disease. Circ J 73: 1381-1385, 2009
44. De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Russell M, Howard BV, Devereux RB: Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: The Strong Heart Study. Hypertension 54: 974-980, 2009
45. McCune TR, Armata T, Mendez-Picon G, Yium J, Zabari GB, Crandall B, Spicer HG, Blanton J, Thacker LR: The Living Organ Donor Network: A model registry for living kidney donors. Clin Transplant 18 Suppl 12: 33-38, 2004
46. Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL: Morbidity and mortality after living kidney donation, 1999-2001: Survey of United States transplant centers. Am J Transplant 3: 830-834, 2003
47. Wainright JL, Davis CL: Short-term complications in recent living kidney donors. Am J Transplant 8: 282, 2008
48. Iseki K: Body mass index and the risk of chronic renal failure: The Asian experience. Contrib Nephrol 151: 42-56, 2006
49. Speckman RA, McClellan WM, Volkova NV, Jurkovitz CT, Satko SG, Schoolwerth AC, Freedman BI: Obesity is associated with family history of ESRD in incident dialysis patients. Am J Kidney Dis 48: 50-58, 2006
50. Hsu CY, McCulloch CE, Irabarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006
51. Iseka K, Ikemiya Y, Fukiyama K: Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int Suppl 55: 69-74, 1996
52. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 1334: 13-18, 1996
53. Perry HM, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowiz DW, Carmody SE: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25: 587-594, 1995
54. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C: Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165: 923-928, 2005
55. Iseki K, Iseki C, Ikemiya Y, Kinjo K, Takishita S: Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res 30: 167-174, 2007
56. Freedman BI, Askandar SS, Appel RG: The link between hypertension and nephrosclerosis. Am J Kidney Dis 25: 207-221, 1995
57. Center for Disease Control: National Health and Nutrition Examination Survey. Available at http://www.cdc.gov/nchs/nhanes.htm. Accessed April 15, 2008
58. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor J, Griffin M, Cosio F, Schwab T, Prieto M, Nyberg S, Ishatani M, Stegall M: Blood pressure and renal failure after kidney donation from hypertensive living donors. Transplantation 78: 276-278, 2004
59. Nogueira JM, Weir MR, Jacobs S, Haririan A, Breault D, Klassen D, Evans D, Bartlett ST, Cooper M: A study of renal outcomes in African American living kidney donors. Transplantation 88: 1371-1376, 2009
60. Herring AA, Woolhandler S, Himmelstein DU: Insurance status of U.S. organ donors and transplant recipients: The uninsured give, but rarely receive. Int J Health Serv 38: 641-652, 2008
61. Ibrahim HN, Rogers T, Tello A, Matas: A:The performance of three serum creatinine-based formulas in estimating GFR in former kidney donors. Am J Transplant 6: 1479-1485, 2006